BIOALLIANCE PHARMA S.A.
Patent Owner
Stats
- 3 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Jul 24, 2012 most recent publication
Details
- 3 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 155 Total Citation Count
- Feb 01, 1993 Earliest Filing
- 19 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
8062669 Vectorization system comprising nanoparticles of homogenous size of at least one polymer and at least one positively charged polysaccharide and method for the preparation thereofExpiredDec 16, 04Nov 22, 11[A61K]
2011/0224,242 STYRLYQUINOLINES, THEIR PROCESS OF PREPARATION AND THEIR THERAPEUTIC USESAbandonedJul 23, 09Sep 15, 11[A61K, C07D, A61P]
2011/0207,685 Oral Formulations of Chemotherapeutic AgentsAbandonedAug 06, 09Aug 25, 11[A61K, B82Y, A61P]
2010/0197,769 PLASMID CONTAINING A SEQUENCE ENCODING A DISINTEGRIN DOMAIN OF METARGIDIN (RDD)AbandonedMar 05, 08Aug 05, 10[A61K, C12N, G01N, A61P]
2010/0120,847 STYRYLQUINOLINES, THEIR PROCESS OF PREPARATION AND THEIR THERAPEUTIC USESAbandonedNov 12, 08May 13, 10[A61K, C07D, A61P]
2009/0286,720 PHARMACEUTICAL COMPOSITION FOR THE DIAGNOSIS, PREVENTION OR TREATMENT OF A TUMORAL PATHOLOGY COMPRISING AN AGENT MODULATING THE POLYMERIZATION STATE OF ACTINAbandonedApr 20, 09Nov 19, 09[A61K, A61P]
2009/0197,906 REVERSION OF MALIGNANT PHENOTYPE WITH 9-HYDROXY ELLIPTICINE DERIVATIVESAbandonedMay 21, 07Aug 06, 09[A61K, C07D]
7491505 Method for analyzing tumor aggressivity comprising measurement of polymerized actinExpiredDec 18, 03Feb 17, 09[G01N]
7479497 Use of quinoline derivatives with anti-integrase effect and applications thereofExpiredMay 15, 03Jan 20, 09[A61K]
2008/0280,849 Synergic Combinations Comprising a Quinoline Compound and Other Hiv Infection Therapeutic AgentsAbandonedJun 01, 05Nov 13, 08[A61K, C07D, A61P]
2008/0161,350 USE OF QUINOLINE DERIVATIVES WITH ANTI-INTEGRASE EFFECT AND APPLICATIONS THEREOFAbandonedMar 05, 08Jul 03, 08[A61K, A61P]
2006/0148,849 Quinoline derivatives, process of synthesis and medicaments containing these derivativesAbandonedMar 01, 06Jul 06, 06[A61K, C07D]
7064133 Quinoline derivatives process of synthesis and medicaments containing these derivativesExpiredOct 14, 02Jun 20, 06[C07D]
7022832 Oligonucleotides containing an antisense sequence stabilized by a secondary structure, pharmaceutical compositions containing them and method of blocking gene expression using themExpiredSep 07, 01Apr 04, 06[C07H]
2004/0253,575 Method for identifying a fuctional biological characteristic of a living matterAbandonedDec 27, 02Dec 16, 04[C12Q]
2004/0191,230 Pharmaceutical composition for the diagnosis, prevention or treatment of a tumoral pathology comprising an agent modulating the polymerization state of actinAbandonedDec 18, 03Sep 30, 04[A61K]
2004/0053,219 Method for analysing human immunodeficiency virus (HIV) phenotypic characteristicsAbandonedMay 13, 03Mar 18, 04[C12Q, C12P]
2003/0207,294 Method for analysing immunodeficiency virus (HIV) phenotypic characteristicsAbandonedOct 04, 02Nov 06, 03[C12Q, C12P]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.